- Home
- OLED vs HALO Comparison
OLED vs HALO Comparison
Compare OLED & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLED
- HALO
- Stock Information
- Founded
- OLED 1985
- HALO 1998
- Country
- OLED United States
- HALO United States
- Employees
- OLED N/A
- HALO N/A
- Industry
- OLED Semiconductors
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OLED Technology
- HALO Health Care
- Exchange
- OLED Nasdaq
- HALO Nasdaq
- Market Cap
- OLED 7.2B
- HALO 7.4B
- IPO Year
- OLED 1992
- HALO N/A
- Fundamental
- Price
- OLED $155.51
- HALO $52.02
- Analyst Decision
- OLED Strong Buy
- HALO Buy
- Analyst Count
- OLED 7
- HALO 9
- Target Price
- OLED $190.43
- HALO $63.56
- AVG Volume (30 Days)
- OLED 710.9K
- HALO 3.1M
- Earning Date
- OLED 05-01-2025
- HALO 05-06-2025
- Dividend Yield
- OLED 1.15%
- HALO N/A
- EPS Growth
- OLED 4.58
- HALO 55.40
- EPS
- OLED 4.81
- HALO 3.76
- Revenue
- OLED $648,702,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- OLED $5.75
- HALO $24.79
- Revenue Next Year
- OLED $10.76
- HALO $22.65
- P/E Ratio
- OLED $31.83
- HALO $13.83
- Revenue Growth
- OLED 6.13
- HALO 25.64
- 52 Week Low
- OLED $103.70
- HALO $41.28
- 52 Week High
- OLED $237.00
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- OLED 68.34
- HALO 39.78
- Support Level
- OLED $139.13
- HALO $47.50
- Resistance Level
- OLED $157.57
- HALO $69.94
- Average True Range (ATR)
- OLED 5.41
- HALO 3.52
- MACD
- OLED 2.57
- HALO -1.49
- Stochastic Oscillator
- OLED 94.44
- HALO 19.64
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.